Literature DB >> 13963594

Hematologic changes observed following I-131 therapy for thyroid carcinoma.

T P HAYNIE, W H BEIERWALTES.   

Abstract

Entities:  

Keywords:  BLOOD CELL COUNT; BLOOD SEDIMENTATION; HEMATOCRIT; HEMOGLOBINOMETRY; IODINE ISOTOPES, THERAPEUTIC; LEUKOCYTE COUNT; THYROID NEOPLASMS

Mesh：

Substances：

Year:  1963        PMID： 13963594

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  5 in total

Review 1.  Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk Patients.

Authors:  E N Klein Hesselink; T P Links
Journal:  Eur Thyroid J       Date:  2015-06-11

Review 2.  Radionuclide therapy revisited.

Authors:  C A Hoefnagel
Journal:  Eur J Nucl Med       Date:  1991

3.  Influence of the first radioactive iodine ablation on peripheral complete blood count in patients with differentiated thyroid cancer.

Authors:  Tianpeng Hu; Zhaowei Meng; Guizhi Zhang; Qiang Jia; Jian Tan; Wei Zheng; Renfei Wang; Xue Li; Na Liu; Pingping Zhou; Arun Upadhyaya
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

4.  Transient Leukopenia After Radioactive Iodine Treatment in Patients With Graves' Disease: A Retrospective Cohort Study.

Authors:  Kaoru Yamashita; Satoshi Morimoto; Shihori Kimura; Yasufumi Seki; Kanako Bokuda; Daisuke Watanabe; Tomoyo Yazaki; Koichiro Abe; Atsuhiro Ichihara
Journal:  J Endocr Soc       Date:  2021-03-06

5.  The Radioprotective Effects of Melatonin and Nanoselenium on DNA Double-Strand Breaks in Peripheral Lymphocytes Caused by I-131.

Authors:  Seyed Masoud Jafarpour; Babak Shekarchi; Hamed Bagheri; Bagher Farhood
Journal:  Indian J Nucl Med       Date:  2021-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.